<DOC>
	<DOCNO>NCT01970709</DOCNO>
	<brief_summary>This multicenter Registry ass whether use pharmacogenomic data result meaningful change subject 's drug dose regimen . In addition , Registry evaluate relationship adverse drug reaction ( ADR ) genotype ass resource utilization ( emergency department visit hospitalization ) associate ADR .</brief_summary>
	<brief_title>Diagnosing Adverse Drug Reactions Registry</brief_title>
	<detailed_description />
	<mesh_term>Drug-Related Side Effects Adverse Reactions</mesh_term>
	<criteria>Subject care coordinate treat physician 's outpatient clinic ; Subject provide write informed consent ; Subject take least three ( 3 ) regularly schedule medication , exclude need ( PRN ) medication , counter medication nutritional supplement ; two ( 2 ) know affected genetic allelic variation . Subject 's treating physician clinical suspicion subject experience adverse sign symptom related prescribed medication achieve intended effect medication . Subject history chronic renal dysfunction , Chronic Kidney Disease Stage 4 5 ; Subject history abnormal hepatic function within last 2 year ( INR &gt; 1.2 attributable anticoagulant medication , AST ( aspartate aminotransferase ) ALT ( alanine aminotransferase ) &gt; 1.5x normal , suspected cirrhosis ) ; Subject history malabsorption ( short gut syndrome ) ; Subject history gastric small bowel surgery ; Subject currently hospitalize ; Subject currently treat intravenous medication ; Subject underwent prior pharmacogenomic testing result report within last 12 month . Subjects may eligible within 60 day date pharmacogenomic testing .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Adverse Drug Reactions</keyword>
	<keyword>Emergency Department Visits</keyword>
	<keyword>Hospitalizations</keyword>
	<keyword>Pharmacogenomic</keyword>
</DOC>